---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-042661"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2025-04-30T23:59:59+00:00"
generated_at: "2026-05-23T02:25:16.699187+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Quoin Pharma regains Nasdaq minimum bid price compliance; delisting risk removed

## Summary
- Received Nasdaq Compliance Notice on April 29, 2025 confirming minimum bid price compliance.
- Closing bid price of ADSs was $1.00 or above for 10 consecutive trading days (April 9-28).
- Nasdaq closed the matter; no further action required from company.

## SEC filing metadata
- accession: 0001104659-25-042661
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2025-04-30T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465925042661/0001104659-25-042661-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925042661/tm2513688d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-042661
- JSON: https://secwatch.observer/filing/0001104659-25-042661.json
- Plain text: https://secwatch.observer/filing/0001104659-25-042661.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.